Lurucapsule 50mg (Pregabalin)

Adult dose

This medication should be taken orally without regard to meals, divided into two doses daily. 1. Neuropathic pain - Peripheral neuropathic pain: Initial dose of 150 mg/day may be increased to 300 mg/day within 3 to 7 days, and if needed, may be further increased up to a maximum of 600 mg/day at intervals of 7 days. - Central neuropathic pain: Initial dose of 150 mg/day may be increased to 300 mg/day after one week.

Child dose

The safety and efficacy data for pediatric patients under 12 years of age and adolescents aged 12-17 years is insufficient; therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, any occurrence of depression or mood changes during use should be reported to a healthcare professional immediately. Do not use this drug if you have an allergy to it or a specific genetic condition causing lactose intolerance. Diabetic patients should be cautious of weight gain and fluctuations in blood sugar, and adjustments to glycemic control medications may be necessary. If severe allergic reactions such as angioedema occur, discontinue use immediately. Elderly patients should be aware of the risk of falls or injuries due to dizziness or drowsiness. Blurry vision or changes in vision may occur; if these symptoms appear, consult a physician. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety; thus, it should be gradually reduced according to a professional's guidance. There is a risk of drug abuse; therefore, it should be used more cautiously in individuals with a history of mental illness or substance abuse. Patients with decreased kidney function may require dosage adjustments. Caution is required in patients with severe heart disease. Taking this medication with other central nervous system depressants or alcohol may increase the risk of drowsiness and respiratory depression; caution is advised. During early pregnancy, there may be risks to the fetus, so women who are pregnant or planning to become pregnant should use it only after consulting a physician. If breastfeeding, this medication can be passed into breast milk, so consult with a healthcare provider regarding breastfeeding. Activities requiring concentration, such as driving or operating machinery, should be avoided until symptoms stabilize after taking this medication. In case of overdose, symptoms such as severe drowsiness, confusion, depression, and seizures may occur, and immediate emergency treatment is necessary. This medication should be stored out of reach of children and should not be transferred to another container.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema
• facial swelling
• periorbital edema
• upper respiratory tract swelling
• chest tightness
• difficulty breathing
• respiratory distress
• respiratory depression

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of direction
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 15 to 30 degrees Celsius. This will help maintain the drug's effectiveness for a longer time.

Appearance

A hard capsule with a dark blue upper part and a white lower part containing a powder that is white to light yellow.

Package unit

Domestic - 30 capsules per bottle